Symposium, S10.4 Emerging antifungal resistant fungi Pathophysiology, Diagnosis, and Management of Chronic Pulmonary Aspergillosis Author: Koichi IZUMIKAWA, M.D., Ph.D. Address: Department of Infectious Diseases Nagasaki University Graduate School of Biomedical Sciences Year: 2022 Symposium, S10.4 Emerging antifungal resistant fungi Pathophysiology, Diagnosis, and Management of Chronic Pulmonary Aspergillosis Slide presentations Select Conference nameAdvances Against Aspergillosis & Mucormycosis (AAAM 9th), Lugano, Switzerland 2020Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, GreeceAdvances against Aspergillosis 3rd Miami USA. January 16-19 2008Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012Advances Against Aspergillosis 8th (AAA) January 2018 Lisbon, PortugalAdvances Against Aspergillosis and Mucormycosis meeting 2024Advances Against Aspergillosis, 1st (AAA) September 2004, San FranciscoAdvances Against Aspergillosis/AAA - 6th 27th Feb - 1st Mar 2014 - Main presentationsAdvances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slidesAnglo-Celtic debate, Dublin 2005, sponsored by PfizerAnnual Meeting of the Infectious Diseases Society of America 47th (IDSA) Oct 29th-Nov 1st 2009Antifungal Drug Development SummitAspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007Aspergillus workshop at the 7th European Conference of Fungal Genetics, Copenhagen, April 2004 (ECFG)Belgian Society for Mycology/ SBIMC Nov 8th, 2012British Mycological Society, 6-8 April 2009 (BMS)British Mycological Society, Annual Scientific Meeting 2005. EXPLOITATION OF FUNGI , University of Manchester: September 5-8 2005 (BMS)British Society for Allergy & Clinical Immunology June 29th - 1st July (BSACI)ECCMID 16th (2006) Nice, FranceECCMID 18th (2008) Barcelona, Spain.ECCMID 20th (2010) Vienna, AustriaECCMID 21st / 27th ICC (2011) Milan, ItalyECCMID 22nd (2012), London, UKECCMID 23rd (2013), Berlin, GermanyECCMID 24th (2014), Barcelona, SpainECCMID 25th (2015) Copenhagen DenmarkECCMID 27th (2017) Vienna , AustriaEuropean Respiratory Society (ERS) Advances in the understanding of Aspergillosis 18th-22nd September, 2010Focus on Fungal Infections 14 meeting, New Orleans, March 2004 (FFI)GeneralHS TalksICAAC 2006 Sept 27-30, San FranciscoICAAC 2014, Washington Sep 5-9ICAAC 47th Chicago September 17-20th 2007ICAAC 50th Boston 12th-15th September, 2010ICAAC, 53rd, Denver September 10-13 2013Indoor Air 2015Infocus 2014Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009International Collaborative Mycology Conference (1st Karachi)International Collaborative Mycology Conference 1st 2017International Union of Microbiological Societies 2011( IUMS) Mycology 6-10th SeptISHAM 2006 June 25-29, Paris 2006ISHAM 2015ISHAM 2022ISHAM 20th (2018) Amsterdam, NetherlandsISHAM Asia 2021ISHAM Tokyo May 25-29 2009New York Academy of Sciences: Invasive aspergillosis - New approaches against a dangerous fungal infectionSecond Research Coordination Meeting of IAEA CRP:Behaviour of Cementitious Materials in Long Term Storage and Disposal of Radioactive WasteSociety for Indian Human & Animal Mycologists 12th (SIHAM) Bengalaru 2018Society for Indian Human & Animal Mycologists 9th (SIHAM), Siliguri, India. Feb 10th-12th 2012TIMM 8th 2017Trends in Medical Mycology 2nd, Berlin, October 2005 (TIMM)Trends In Medical Mycology 3rd (TIMM)Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM) Showing 10 posts of 557 posts found. Title Author Year Gliotoxin: Biosynthesis and biological activities DH Scharf 2024 Inhibition of pyrimidine biosynthesis and salvage Assoc. Prof. Fabio Gsaller, PhD 2024 Overview of Inhaled Mycotoxins from Indoor Exposure & Human Illness Dr. Irene Grant 2024 Updated definition of allergic bronchopulmonary aspergillosis (ABPA) and assessment of therapeutic response Ritesh Agarwal MD, DM 2024 Induced immunological defects in virus-associated pulmonary aspergillosis (VAPA) Joost Wauters, MD, PhD Simon Feys, MD and Laura Seldeslachts, MSc 2024 Eosinophils or IgE–which determines response to biologics in ABPA? Koichiro Asano 2024 Optimal antifungal strategies to prevent mould infections deaths in solid organ transplant recipients Maricela Valerio Minero, MD, PhD 2024 Optimal antifungal strategies to prevent mould infections deaths in ICU patients Daniele Roberto Giacobbe, MD, PhD 2024 Panaccione 0900 Saturday session 11 Ergot alkaloids 2024 PoC tests for antigen and antibody – Are they really point of care? Robina Aerts, MD 2024 12345678910...56Next
